Halozyme Therapeutics (HALO) Tops Q2 EPS by 47c; raises guidance
Go back to Halozyme Therapeutics (HALO) Tops Q2 EPS by 47c; raises guidance| Halozyme Therapeutics, Inc. (NASDAQ: HALO) | Delayed: 101.82 -0.8 (0.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.62 | 52 Week High | $18.39 | |||
| Open | $102.00 | 52 Week Low | $6.96 | |||
| Day High | $102.49 | P/E | N/A | |||
| Day Low | $100.47 | EPS | $-0.58 | |||
| Volume | 426,231 | |||||
